Newmont Corporation (FRA:NMM)

Intra-Cellular Therapies Revenue

Newmont had revenue of $5.32B USD in the quarter ending June 30, 2025, with 20.79% growth. This brings the company's revenue in the last twelve months to $20.58B, up 38.38% year-over-year. In the year 2024, Newmont had annual revenue of $18.68B with 58.16% growth.

• Revenue (ttm): $20.58B
• Revenue Growth: +38.38%
• P/S Ratio: 3.40
• Revenue / Employee: $927.21K
• Employees: 22,200
• Market Cap: 59.55B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	18.68B	6.87B	58.16%
Dec 31, 2023	11.81B	-103.00M	-0.86%
Dec 31, 2022	11.92B	-307.00M	-2.51%
Dec 31, 2021	12.22B	725.00M	6.31%
Dec 31, 2020	11.50B	1.76B	18.04%